Literature DB >> 23450716

The efficiency of the serum prostate specific antigen levels in diagnosing prostatic enlargements.

Ingle Sp1, Ingle Ramona.   

Abstract

BACKGROUND: The objective of this study was to evaluate the serum PSA levels in patients presenting with enlarged prostate and to evaluate the efficiency of serum PSA to diagnose and differentiate benign and malignant enlargements.
METHODS: The authors evaluated the patients coming in surgical OPD with enlarged prostate and were advised to undergo serum PSA testing.
RESULTS: The efficiency of serum PSA to differentiate Benign and malignant lesions was 97.18% and 83.33% respectively.

Entities:  

Keywords:  Prostate Specific Antigen

Year:  2012        PMID: 23450716      PMCID: PMC3576757          DOI: 10.7860/JCDR/2012/4926.2676

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  23 in total

1.  Early prostate cancer: radical prostatectomy or watchful waiting.

Authors:  Anil Mandhani
Journal:  Natl Med J India       Date:  2005 Jul-Aug       Impact factor: 0.537

2.  Pilot study of screening for prostate cancer in general practice.

Authors:  D J Chadwick; T Kemple; J P Astley; A G MacIver; D A Gillatt; P Abrams; J C Gingell
Journal:  Lancet       Date:  1991-09-07       Impact factor: 79.321

3.  The role of prostate-specific antigen as part of the diagnostic triad and as a guide when to perform a biopsy.

Authors:  R J Babaian; J L Camps
Journal:  Cancer       Date:  1991-11-01       Impact factor: 6.860

4.  Diagnosis of prostate cancer: optimal number of prostate biopsies related to serum prostate-specific antigen and findings on digital rectal examination.

Authors:  G Aus; G Ahlgren; J Hugosson; K V Pedersen; K Rensfeldt; R Söderberg
Journal:  Scand J Urol Nephrol       Date:  1997-12

5.  Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels.

Authors:  R B Nadler; P A Humphrey; D S Smith; W J Catalona; T L Ratliff
Journal:  J Urol       Date:  1995-08       Impact factor: 7.450

Review 6.  A guide to the interpretation of serum prostate specific antigen levels.

Authors:  P S Bunting
Journal:  Clin Biochem       Date:  1995-06       Impact factor: 3.281

7.  Biopsy-proved prostate cancer in 100 consecutive men with benign digital rectal examination and elevated serum prostate-specific antigen level. Prevalence and pathologic characteristics.

Authors:  D A Guthman; T M Wilson; M L Blute; E J Bergstralh; H Zincke; J E Oesterling
Journal:  Urology       Date:  1993-08       Impact factor: 2.649

8.  Diagnostic methods in the detection of prostate cancer: a study of a randomly selected population of 2,400 men.

Authors:  O Gustafsson; U Norming; L E Almgård; A Fredriksson; G Gustavsson; B Harvig; C R Nyman
Journal:  J Urol       Date:  1992-12       Impact factor: 7.450

9.  Evaluation of age-specific normal ranges for prostate-specific antigen.

Authors:  V O Speights; P N Brawn; D M Foster; A M Spiekerman; D Kuhl; M W Riggs
Journal:  Urology       Date:  1995-03       Impact factor: 2.649

10.  Prostate cancer screening: role of the digital rectal examination and prostate-specific antigen.

Authors:  J P Richie; L R Kavoussi; G T Ho; M A Vickers; M A O'Donnell; D St Laurent; A Chen; D S Goldstein; K R Loughlin
Journal:  Ann Surg Oncol       Date:  1994-03       Impact factor: 5.344

View more
  1 in total

1.  Characterization of Monoclonal and Polyclonal Antibodies Recognizing Prostate Specific Antigen: Implication for Design of a Sandwich ELISA.

Authors:  Sahar Raoofi Mohseni; Forough Golsaz-Shirazi; Mostafa Hosseini; Jalal Khoshnoodi; Tannaz Bahadori; Mohammad Ali Judaki; Mahmood Jeddi-Tehrani; Fazel Shokri
Journal:  Avicenna J Med Biotechnol       Date:  2019 Jan-Mar
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.